Pfizer Inc (NYSE: PFE) on Friday, soared 1.07% from the previous trading day, before settling in for the closing price of $27.08. Within the past 52 weeks, PFE’s price has moved between $20.92 and $30.43.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -13.27%. The company achieved an average annual earnings per share of -0.74%. With a float of $5.68 billion, this company’s outstanding shares have now reached $5.68 billion.
Pfizer Inc (PFE) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Pfizer Inc is 0.11%, while institutional ownership is 66.71%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 1.06 earnings per share (EPS) for the period topping the consensus outlook (set at 0.61) by 0.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.06% during the next five years compared to -13.27% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Pfizer Inc (PFE) is currently performing well based on its current performance indicators. A quick ratio of 0.85 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.44. Likewise, its price to free cash flow for the trailing twelve months is 12.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.88, a number that is poised to hit 0.71 in the next quarter and is forecasted to reach 3.15 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Compared to the last year’s volume of 46.74 million, its volume of 99.03 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 92.15%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 94.41%, which indicates a significant increase from 92.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.62 in the past 14 days, which was higher than the 0.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.68, while its 200-day Moving Average is $24.83. Nevertheless, the first resistance level for the watch stands at $27.70 in the near term. At $28.02, the stock is likely to face the second major resistance level. The third major resistance level sits at $28.35. If the price goes on to break the first support level at $27.04, it is likely to go to the next support level at $26.71. Now, if the price goes above the second support level, the third support stands at $26.39.
Pfizer Inc (NYSE: PFE) Key Stats
Market capitalization of the company is 155.61 billion based on 5,685,551K outstanding shares. Right now, sales total 63,627 M and income totals 8,031 M. The company made 14,653 M in profit during its latest quarter, and 2,910 M in sales during its previous quarter.
